Quick agreement reached after a week of negotiations, likely to be implemented in October
It appears that the single agent for colds, Pseudoephedrine, will be subject to increased drug prices starting in October. There is news that drug price adjustment negotiations with the NHIS, which have been ongoing since last week, have been concluded. Attention is being paid to whether this drug price increase will increase the supply of products from pharmaceutical companies and alleviate supply and demand difficulties. According to the industry on the 19th, the corporation and pharmaceutical companies agreed to increase the price of 60mg of single drug Pseudoephedrine HCl. It is said that negotiations were concluded a